Last update:

Medications news

Medications

Clopidogrel edges out aspirin in heart procedure recovery

Researchers at 37 sites in South Korea have found patients taking clopidogrel after percutaneous coronary intervention (PCI) experienced lower rates of both thrombotic and bleeding events than those taking aspirin. Clopidogrel's ...

Medications

Horseshoe crab and tarantula-derived peptides may provide key to beating drug-resistant melanoma

Antimicrobial peptides derived from a crab and a spider may provide the pathway to overcoming drug resistance in advanced melanoma. QUT researchers based at Brisbane's Translational Research Institute (TRI) have modified ...

Medications

Diabetes drug linked to increased risk of severe eye condition

Two independent studies from the University of Southern Denmark (SDU) show that patients with type 2 diabetes who are treated with the drug Ozempic have an increased risk of developing damage to the optic nerve of the eye, ...

Medications

St John's wort: Six drug interactions you should know about

St John's wort is an herbal supplement that has been used for centuries to boost mood. Even today, many people use it as a natural treatment for mild to moderate depression. St John's wort contains several active compounds, ...

Medications

A new class of antivirals could help prevent future pandemics

The arrival of Paxlovid in December 2021 marked another turning point in the COVID-19 pandemic—an effective antiviral that has since successfully treated millions. But like many antivirals before it, scientists know that ...

Medications

Exploring opioid-free pain relief in bariatric surgery

Obese patients undergoing bariatric surgery can manage without opioids, according to a thesis from the University of Gothenburg. The research is paving the way for opioid-free treatment during and after surgery.

Medications

Trial data underpins FDA approval of omalizumab for food allergy

Today's Food and Drug Administration approval of a supplemental biologics license for the monoclonal antibody omalizumab (Xolair) highlights the vital role of the National Institutes of Health-supported research that underpins ...

Medications

Cefepime-taniborbactam superior to meropenem for complicated UTI

For adults with complicated urinary tract infection (UTI), including acute pyelonephritis, cefepime-taniborbactam is superior to meropenem, according to a study published in the Feb. 15 issue of the New England Journal of ...

Medications

FDA approves iloprost for severe frostbite

Aurlumyn (iloprost), a vasodilator, has been approved by the U.S. Food and Drug Administration to treat severe frostbite. The injected medication lowers the risk for finger or toe amputation.

Medications

How a novel drug pushes the HIV capsid to breaking point

Just over a year ago, the European Union and the US Food and Drug Administration approved a new anti-retroviral drug to treat human immunodeficiency virus (HIV) infections. Lenacapavir is the first drug available to patients ...

Medications

Obesity medicine's foggy future is getting clearer

The biggest quandary in the obesity drug market is that nobody knows just how big it will be. Everyone agrees it'll be huge—currently, Eli Lilly & Co. is worth more than Tesla Inc., and Novo Nordisk A/S is at times the ...